Search research articles
Contact Us
Filters
Showing results (541-550 of 604) with videos related to
Page
of 61
Sort By:
JAMA
|
July 13, 2018
Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial
Dawn L Hershman, Joseph M Unger, Heather Greenlee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 17, 2013
A comparative analysis of prognostic factor models for follicular lymphoma based on a phase III trial of CHOP-rituximab versus CHOP + 131iodine--tositumomab
Oliver W Press, Joseph M Unger, Lisa M Rimsza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 2012
Phase III randomized intergroup trial of CHOP plus rituximab compared with CHOP chemotherapy plus (131)iodine-tositumomab for previously untreated follicular non-Hodgkin lymphoma: SWOG S0016
Oliver W Press, Joseph M Unger, Lisa M Rimsza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 15, 2017
Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202
N Lynn Henry, Joseph M Unger, Anne F Schott, et al.
JAMA Oncology
|
January 18, 2019
Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices
Scott D Ramsey, Joseph M Unger, Laurence H Baker, et al.
Blood
|
June 12, 2008
Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP
Lisa M Rimsza, Michael L Leblanc, Joseph M Unger, et al.
JAMA Oncology
|
November 23, 2022
Effectiveness of Adjuvant Pembrolizumab vs High-Dose Interferon or Ipilimumab for Quality-of-Life Outcomes in Patients With Resected Melanoma: A Secondary Analysis of the SWOG S1404 Randomized Clinical Trial
Joseph M Unger, Amy Darke, Megan Othus, et al.
Future Oncology (London, England)
|
March 28, 2025
S2303: phase II/III trial of paclitaxel + ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE)
Anwaar Saeed, Sarah Colby, Paul Eliezer Oberstein, et al.
JAMA Oncology
|
December 17, 2020
Association of Osteonecrosis of the Jaw With Zoledronic Acid Treatment for Bone Metastases in Patients With Cancer
Catherine H Van Poznak, Joseph M Unger, Amy K Darke, et al.
JCO Oncology Practice
|
October 6, 2025
ASCO State of Cancer Care in America Special Report 2025: Access to Cancer Clinical Trials in the United States
Erin P Balogh, Laura A Levit, Joseph M Unger, et al.
Page
of 61
Search research articles
Search
Showing results (541-550 of 604) with videos related to
Sort By:
Page
of 61
JAMA
|
July 13, 2018
Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial
Dawn L Hershman, Joseph M Unger, Heather Greenlee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 17, 2013
A comparative analysis of prognostic factor models for follicular lymphoma based on a phase III trial of CHOP-rituximab versus CHOP + 131iodine--tositumomab
Oliver W Press, Joseph M Unger, Lisa M Rimsza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 2012
Phase III randomized intergroup trial of CHOP plus rituximab compared with CHOP chemotherapy plus (131)iodine-tositumomab for previously untreated follicular non-Hodgkin lymphoma: SWOG S0016
Oliver W Press, Joseph M Unger, Lisa M Rimsza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 15, 2017
Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202
N Lynn Henry, Joseph M Unger, Anne F Schott, et al.
JAMA Oncology
|
January 18, 2019
Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices
Scott D Ramsey, Joseph M Unger, Laurence H Baker, et al.
Blood
|
June 12, 2008
Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP
Lisa M Rimsza, Michael L Leblanc, Joseph M Unger, et al.
JAMA Oncology
|
November 23, 2022
Effectiveness of Adjuvant Pembrolizumab vs High-Dose Interferon or Ipilimumab for Quality-of-Life Outcomes in Patients With Resected Melanoma: A Secondary Analysis of the SWOG S1404 Randomized Clinical Trial
Joseph M Unger, Amy Darke, Megan Othus, et al.
Future Oncology (London, England)
|
March 28, 2025
S2303: phase II/III trial of paclitaxel + ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE)
Anwaar Saeed, Sarah Colby, Paul Eliezer Oberstein, et al.
JAMA Oncology
|
December 17, 2020
Association of Osteonecrosis of the Jaw With Zoledronic Acid Treatment for Bone Metastases in Patients With Cancer
Catherine H Van Poznak, Joseph M Unger, Amy K Darke, et al.
JCO Oncology Practice
|
October 6, 2025
ASCO State of Cancer Care in America Special Report 2025: Access to Cancer Clinical Trials in the United States
Erin P Balogh, Laura A Levit, Joseph M Unger, et al.
Page
of 61